Hopes are dimming that the drug industry will be able to quickly deliver a treatment for one of the most keenly researched diseases of recent years—an inherited muscle-wasting disorder called Duchenne muscular dystrophy.
from WSJ.com: US Business http://ift.tt/1Sy5vCK
via IFTTT
No comments:
Post a Comment